Pliant Therapeutics Names David Raben Chief Medical Officer
Pliant Therapeutics, Inc. has appointed David Raben, M.D., as its Chief Medical Officer. Dr. Raben brings over three decades of experience in academic and biopharmaceutical oncology to the clinical-stage biotechnology company.